Menthone is a minty monoterpene ketone that commonly sits behind menthol as a major support constituent in peppermint and cornmint profiles, and it can also appear at lower levels in geranium materials. The strongest public evidence is for identity, repeated occurrence, flavor-use safety evaluation, and a smaller preclinical literature touching inflammatory signaling. Human constituent-specific evidence remains thin, so AromaForge should position menthone mainly as a chemistry-and-mechanism marker rather than a validated standalone wellness active.
Chemical identity and composition
PubChem and JECFA identify menthone as C10H18O and commonly describe the evaluated flavoring material as trans-p-menthan-3-one. In aromatic raw materials it frequently appears with isomenthone, and some literature or commercial records distinguish enantiomeric forms explicitly.
Aroma and practical use
- Use the recorded minty, fresh, herbal, ketonic, herbaceous descriptors to explore a blend's scent character; perceived strength also depends on the other ingredients.
- Compare the recorded goal signals with the intended purpose, while keeping model assumptions separate from observed study outcomes.
- Read the route, preparation and experimental context before using a study finding to choose an oil.
Reported benefits and effects
Findings retain their study context. An animal or laboratory result describes that experiment.
allergic airway inflammation model
A 2022 mouse study reported that menthone inhalation alleviated local and systemic allergic inflammation in asthmatic mice.
Measured: local and systemic allergic inflammation measures
This experimental finding does not establish benefit, dose or safety in people using this blend.
raw264 7 inflammation assay
A cell study reported that menthone suppressed LPS-induced pro-inflammatory cytokine production through inhibition of IkappaB kinase activation in macrophages.
Measured: LPS-induced IL-1beta and TNF-alpha production
This experimental finding does not establish benefit, dose or safety in people using this blend.
type i interferon pathway modulation
A 2022 study reported that menthone inhibited type I interferon signaling by promoting TYK2 ubiquitination, linking the constituent to an experimentally defined inflammatory pathway.
Measured: type I interferon signaling and TYK2 regulation
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
How it contributes to goal calculations
Model markers guide the formulation score. They are separate from the source findings above.
Use concerns and concentration limits
Sensitization concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Phototoxicity concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Oxidation concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Penetration enhancementNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
A recorded constituent reference, not a recommended oil dilution. Product category, source applicability and all contributing oils must be checked before use.
unverified reference · No source provenance attachedWHO/JECFA and FAO/JECFA flavoring records describe menthone as having no safety concern at current levels of intake when used as a flavoring agent.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
That flavor-use conclusion should not be stretched into broad statements about concentrated dermal, inhalation, or therapeutic use of isolated menthone.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
This pass did not verify a direct constituent-specific modern dermal maximum or fragrance-use dossier analogous to more extensively reviewed fragrance ingredients.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
Constituents it may interact with
No constituent-pair interaction is recorded for this identity. The report does not assume either amplification or incompatibility.
How the effects were investigated
reduced lps induced proinflammatory cytokines
A macrophage-focused study reported that menthone suppressed LPS-induced IL-1beta and TNF-alpha production, supporting a constituent-specific anti-inflammatory signal in vitro.
This experimental finding does not establish benefit, dose or safety in people using this blend.
tyk2 ubiquitination and type i interferon suppression
A rheumatoid-arthritis-oriented mechanistic paper reported that menthone promoted TYK2 ubiquitination and inhibited type I interferon signaling in its experimental system.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
What this report cannot establish
- A reported constituent percentage does not establish an effective human therapeutic dose or the amount absorbed into the body.
- The presence of a constituent does not guarantee a clinical benefit, rash treatment or sleep improvement from a custom blend.
- An unflagged concern or missing use limit does not establish safety for ingestion, inhalation, skin exposure or a particular person.
- A candidate constituent interaction does not establish that two oils amplify one another at the selected proportions.
- Constituent descriptors alone do not establish a precise top, heart or base lifetime in a finished blend.
Known data gaps (4)
- No robust human clinical literature centered on isolated menthone was verified in this pass.
- Several menthone bioactivity papers are pathway-specific and preclinical, so the evidence base is still too narrow for strong consumer-facing functional claims.
- The numeric dermal reference lacks source provenance; a verified flag alone is insufficient.
- Some findings do not record an explicit exposure route; consult the linked study before applying them to a use.